Richard Prins - Oct 17, 2025 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
/s/ Richard Prins
Stock symbol
IGC
Transactions as of
Oct 17, 2025
Transactions value $
$0
Form type
4
Date filed
10/22/2025, 08:29 AM
Previous filing
Jun 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PRINS RICHARD K Director 10224 FALLS ROAD, POTOMAC /s/ Richard Prins 2025-10-22 0001047579

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Options Award $0 +750K $0.00 750K Oct 17, 2025 Common Stock 750K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 750,000 options exercisable at $0.35, equally vesting over the next three years starting on March 31st, 2026.